UBS Raises Price Target, Estimates on Aetna (AET)

UBS Raises Price Target, Estimates on Aetna (AET)


UBS analysts raised their price target and earnings estimates on health care benefits provider Aetna Inc (AET) on Tuesday, as they expect that the company’s medical claim trends should continue and that Coventry Health Care synergies should be better than expected.

The analysts see shares of AET reaching $76, which suggests a 10.6% upside to the stock’s Monday closing price of $68.71.

Aetna shares were down 73 cents, or 1.06%, during early morning trading on Tuesday. The stock is up 47.07% year-to-date.

The Bottom Line

Shares of Aetna (AET) offer a dividend yield of 1.17% based on Tuesday’s intraday trading price of $68.52 and the company’s annualized dividend payout of 80 cents per share.

Aetna Inc (AET) is not recommended at this time, holding a DARS™ Rating of 3.4 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.

Free Updates

Join over 100,000 investors who get the latest news from

Best Dividend Stocks

Looking for stocks that are poised for growth and pay solid dividends? Visit our list of the:

Best Dividend Stocks

Partner Center

Best CD Rates

Sitting on some extra cash and looking for the most current and profitable CD Rates?

Get The Best CD Rates

14 Day Free Trial

Earn more from your dividend portfolio within the next 14 days.

Sign Up Today